Bayer is facing demands from activist investor Bluebell Capital Partners to break up, a person familiar with the matter told Reuters, pushing shares in the diversified health and agriculture group to a five-week high.
The source said Bluebell had invested in Bayer (OTC:BAYRY) a few months ago and is pushing for a sale of the company’s consumer health unit and, at a later stage, for a separation of Bayer’s pharmaceuticals and agriculture businesses.
